NCT03775876 is a Phase 4 clinical trial of Shoulder Arthroscopy in Hemodynamic, sponsored by Saint-Joseph University.

Who is sponsoring NCT03775876?

NCT03775876 is sponsored by Saint-Joseph University.

What drugs are being tested in NCT03775876?

Interventions in NCT03775876: Shoulder Arthroscopy, Regional Block, Propofol, Dexmedetomidine, BIS.

What condition does NCT03775876 study?

NCT03775876 studies Hemodynamic, Sedation, Satisfaction, Personal.

Is NCT03775876 still recruiting?

NCT03775876 is currently completed. Last updated 17 December 2018.

Last reviewed 2018-12-17 · How we verify

NCT03775876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexmedetomidine Versus Propofol in Conjunction With Regional Block for Shoulder Arthroscopy

Completed Phase 4 Last updated 17 December 2018

What this trial tests

Phase 4 trial testing Shoulder Arthroscopy in Hemodynamic in 60 participants. Completed in 15 September 2018.

Timeline

1 March 2017

Primary endpoint
1 March 2018

15 September 2018

Quick facts

Lead sponsor	Saint-Joseph University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	60
Start date	1 March 2017
Primary completion	1 March 2018
Estimated completion	15 September 2018
Sites	1 location across Lebanon

Drugs / interventions tested

Shoulder Arthroscopy
Regional Block — full drug profile →
Propofol (Propofol) — full drug profile →
Dexmedetomidine (dexmedetomidine) — full drug profile →
BIS

Conditions studied

Hemodynamic — all drugs for Hemodynamic →
Sedation — all drugs for Sedation →
Satisfaction, Personal — all drugs for Satisfaction, Personal →

Sponsor

Saint-Joseph University

Who can join

Adults 18 to 80, any sex, with Hemodynamic or Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Operative shoulder arthroscopy under regional block anesthesia often presents with hemodynamic challenges for the anesthesiologist, knowing that a low systolic blood pressure is required to minimize the bleeding. Regional anesthesia is successfully performed to many patients in whom tracheal intubation or the placement of a laryngeal tube is undesired. Propofol has traditionally been used to provide sedation in patients undergoing shoulder arthroscopy under regional anesthesia. In contrast to Propofol, Dexmedetomidine is a highly selective α-2 adrenoceptor agonist that has been shown to provide sedation, analgesia and anxiolytic effects with minimal respiratory depression. Due to the effect of both drugs on blood pressure, the investigators set out to compare intraoperative hemodynamics of both drugs, along with the surgeon's satisfaction and the degree of comfort provided to patients undergoing interscalene brachial plexus block for shoulder arthroscopy. The investigators also assessed whether the type of anesthetic agent used for sedation accounted for other differences in intra and post-operative outcome measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Shoulder Arthroscopy

Trials testing the same drug.

NCT01623011 — Can Shoulder Arthroscopy Work · NA · completed

Other recruiting trials for Hemodynamic

Currently open trials in the same condition.

NCT06871150 — Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization Du · NA · recruiting
NCT07309705 — Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis · active not recruiting
NCT07309718 — MPR for Stroke Risk Assessment of ICAS · recruiting
NCT06984302 — A PREDICTIVE ALGORITHM IN AORTIC SURGERY · NA · recruiting
NCT06772038 — Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion · recruiting

Other Saint-Joseph University trials

Trials by the same sponsor.

NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
NCT07350746 — A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a · NA · active not recruiting
NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
NCT07525128 — Lateral GBR Using Two Types of Membrane With a Combination of Allograft-xenograft · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03775876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint-Joseph University
Last refreshed: 17 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03775876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing